Pimentel Isabelle Spirandelli, Pimentel Victor Spirandelli, Faloppa Flavio, Belloti João Carlos, Tamaoki Marcel Jun Sugawara, Pimentel Benedito Felipe Rabay
Faculdade de Medicina de Petrópolis, Centro Universitário Arthur Sá Earp Neto (Unifase), Petrópolis, RJ, Brasil.
Departamento de Ortopedia e Traumatologia, Irmandade da Santa Casa de Misericórdia de São Paulo (ISCMSP), São Paulo, SP, Brasil.
Rev Bras Ortop (Sao Paulo). 2024 Mar 21;59(1):e54-e59. doi: 10.1055/s-0044-1779318. eCollection 2024 Feb.
To evaluate the usefulness of the Phalen test and the Tinel sign in the prognosis and the impact on quality of life in the clinical course of patients with carpal tunnel syndrome undergoing surgical treatment through the traditional open approach. The present is a cohort study on prognosis. We included 115 patients with high probability of receiving a clinical diagnosis of carpal tunnel syndrome with indication for surgical treatment. All patients underwent the Phalen test and Tinel sign and answered the Boston Carpal Tunnel Questionnaire before and after the surgical treatment. The estimates for the probability of the time until remission of the Phalen test at 2, 4 and 16 weeks postoperatively were of 3.54% (95% confidence interval [95%CI]: 1.16%-8.17%), 0.88% (95%CI: 0.08%-4.38%) and 0.88% (95%CI: 0.08% to 4.38%) respectively, and, for the Tinel sign, they were of 12.39% (95%CI: 7.13%-19.18% ), 4.42% (95%CI : 1.65%-9.36%) and 2.65% (95%CI : 0.70%-6.94%) respectively. There was a reduction in the postoperative score on the Boston Carpal Tunnel Questionnaire of 1.8 points for symptom severity ( < 0.001) and of 1.6 points for functional status ( < 0.001). Phalen test remission was earlier than that of the Tinel sign, but, when performed as of the second postoperative week, they were prognostic factors favorable to the clinical course, with improved quality of life.
评估Phalen试验和Tinel征在接受传统开放手术治疗的腕管综合征患者临床过程中的预后作用及对生活质量的影响。 本研究是一项关于预后的队列研究。我们纳入了115例临床诊断为腕管综合征且有手术指征的高概率患者。所有患者在手术治疗前后均接受了Phalen试验和Tinel征检查,并回答了波士顿腕管综合征问卷。 术后2周、4周和16周Phalen试验缓解时间的概率估计分别为3.54%(95%置信区间[95%CI]:1.16%-8.17%)、0.88%(95%CI:0.08%-4.38%)和0.88%(95%CI:0.08%至4.38%),对于Tinel征,其概率估计分别为12.39%(95%CI:7.13%-19.18%)、4.42%(95%CI:1.65%-9.36%)和2.65%(95%CI:0.70%-6.94%)。波士顿腕管综合征问卷术后症状严重程度评分降低了1.8分(<0.001),功能状态评分降低了1.6分(<0.001)。 Phalen试验缓解早于Tinel征,但从术后第二周开始,它们都是有利于临床过程且生活质量改善的预后因素。